Memantine - Communication Study

Clinical trial NCT00624026 · COMPLETED

Trial details

NCT number: NCT00624026
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2007-11-01
Primary completion: 2008-12-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.